GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Bearish flow noted in GSK (GSK) Pharma with 2,296 puts trading, or 1.2x expected. Most active are May-25 30 puts and Dec-24 38 calls, with total volume in those strikes near 2,500 contracts.
Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, ...
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
GlobalData on MSN5d
GSK CEO addresses declining trust in vaccines following Trump re-electionGSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...
GlaxoSmithKline is under pressure from shareholders ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...
DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...
Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...
Creative Bloq on MSN2h
The Guggenheim’s new logo is a modern masterpieceAligning its historic vision and creative values across its four locations, the Guggenheim has unveiled a powerful new brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback